GB9704498D0 - Chemical compound - Google Patents

Chemical compound

Info

Publication number
GB9704498D0
GB9704498D0 GBGB9704498.6A GB9704498A GB9704498D0 GB 9704498 D0 GB9704498 D0 GB 9704498D0 GB 9704498 A GB9704498 A GB 9704498A GB 9704498 D0 GB9704498 D0 GB 9704498D0
Authority
GB
United Kingdom
Prior art keywords
chemical compound
chemical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9704498.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Glaxo Wellcome SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome SpA filed Critical Glaxo Wellcome SpA
Priority to GBGB9704498.6A priority Critical patent/GB9704498D0/en
Publication of GB9704498D0 publication Critical patent/GB9704498D0/en
Priority to SK1196-99A priority patent/SK119699A3/en
Priority to CN98803053A priority patent/CN1249750A/en
Priority to IDW990976A priority patent/ID24207A/en
Priority to EA199900710A priority patent/EA199900710A1/en
Priority to EEP199900387A priority patent/EE9900387A/en
Priority to AU68251/98A priority patent/AU6825198A/en
Priority to CO98011404A priority patent/CO4940415A1/en
Priority to APAP/P/1999/001637A priority patent/AP9901637A0/en
Priority to PCT/EP1998/001146 priority patent/WO1998039327A1/en
Priority to ARP980100948A priority patent/AR011178A1/en
Priority to KR1019997007987A priority patent/KR20000075907A/en
Priority to TR1999/02117T priority patent/TR199902117T2/en
Priority to PL98335652A priority patent/PL335652A1/en
Priority to HU0002109A priority patent/HUP0002109A2/en
Priority to YU43499A priority patent/YU43499A/en
Priority to BR9808305-8A priority patent/BR9808305A/en
Priority to ZA9801791A priority patent/ZA981791B/en
Priority to CA002282851A priority patent/CA2282851A1/en
Priority to NZ337315A priority patent/NZ337315A/en
Priority to EP98913613A priority patent/EP0966463A1/en
Priority to JP53813598A priority patent/JP2001513796A/en
Priority to PE1998000149A priority patent/PE51399A1/en
Priority to IL13148998A priority patent/IL131489A0/en
Priority to HR9704498.6A priority patent/HRP980114A2/en
Priority to IS5166A priority patent/IS5166A/en
Priority to OA9900201A priority patent/OA11154A/en
Priority to NO994303A priority patent/NO994303L/en
Priority to BG103779A priority patent/BG103779A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB9704498.6A 1997-03-05 1997-03-05 Chemical compound Pending GB9704498D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound
IL13148998A IL131489A0 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylphyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
HU0002109A HUP0002109A2 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
BR9808305-8A BR9808305A (en) 1997-03-05 1998-03-03 Crystalline hydrated form, process for the preparation of hydrated crystalline form, pharmaceutical composition, process for treating a mammal, and process for treating or preventing pain.
YU43499A YU43499A (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2- carboxylic acid
EA199900710A EA199900710A1 (en) 1997-03-05 1998-03-03 CRYSTAL HYDRATED SODIUM SALT (E) -4,6-DICHLOR-3- (2-OXO-1-phenylpyrrolidine-3-ilidene-methyl) -1H-indol-2-carboxylic acid
CN98803053A CN1249750A (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid
AU68251/98A AU6825198A (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
CO98011404A CO4940415A1 (en) 1997-03-05 1998-03-03 CHEMICAL COMPOUND
APAP/P/1999/001637A AP9901637A0 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
PCT/EP1998/001146 WO1998039327A1 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
ARP980100948A AR011178A1 (en) 1997-03-05 1998-03-03 SODIUM SALT COMPOUND OF (ACID (E) 4,6-DICHLORO-3- (2-OXO-1- FENILPIRROLIDIN-3-ILIDENO-METHYL) -1H-INDOL-2-CARBOXILICO IN ITS HYDRATED FORM, PROCESS FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT AND METHOD OF TREATMENT USING SUCH COMPOUND
KR1019997007987A KR20000075907A (en) 1997-03-05 1998-03-03 Crystalline Hydrated Sodium Salt of (E)-4,6-Dichloro-3-(2-Oxo-1-Phenylpyrrolidin-3-ylidene Methyl)-1H-Indole-2- Carboxylic Acid
ZA9801791A ZA981791B (en) 1997-03-05 1998-03-03 Chemical compound.
PL98335652A PL335652A1 (en) 1997-03-05 1998-03-03 Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid
SK1196-99A SK119699A3 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo- -1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
IDW990976A ID24207A (en) 1997-03-05 1998-03-03 NATRIUM SALT THAT CRYSTALIN FROM ACID (E) -4,6-DIKLORO-3- (2-OKSO-1-ENILPIROLIDIN-3-METHYLE ILIDENE) -1-H-INDOLA-2-CARBOXICATE
EEP199900387A EE9900387A (en) 1997-03-05 1998-03-03 Crystalline hydrate of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenemethyl) -1H-indole-2-carboxylic acid, sodium salt
TR1999/02117T TR199902117T2 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (E)-4,6-Dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
CA002282851A CA2282851A1 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
NZ337315A NZ337315A (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid and it's use in the treatment of pain
EP98913613A EP0966463A1 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
JP53813598A JP2001513796A (en) 1997-03-05 1998-03-03 (E) Crystalline sodium salt hydrate of 4,6-dichloro-3- (2-oxo-1-phenylpyrrolidine-3-ylidenemethyl) -1H-indole-2-carboxylic acid
PE1998000149A PE51399A1 (en) 1997-03-05 1998-03-03 HYDRATED CRYSTALLINE FORM OF SODIUM SALT ACID (E) -4,6-DICHLORO-3- (2-OXO-1-FENILPIRROLIDIN-3-ILIDENO-METHYL) -1H-INDOL-2-CARBOXILICO
HR9704498.6A HRP980114A2 (en) 1997-03-05 1998-03-04 Chemical compound
IS5166A IS5166A (en) 1997-03-05 1999-08-27 Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid
OA9900201A OA11154A (en) 1997-03-05 1999-09-02 Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid
NO994303A NO994303L (en) 1997-03-05 1999-09-03 Crystalline hydrated sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidenomethyl) -1H-indole-2-carboxylic acid
BG103779A BG103779A (en) 1997-03-05 1999-10-04 Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
GB9704498D0 true GB9704498D0 (en) 1997-04-23

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9704498.6A Pending GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Country Status (29)

Country Link
EP (1) EP0966463A1 (en)
JP (1) JP2001513796A (en)
KR (1) KR20000075907A (en)
CN (1) CN1249750A (en)
AP (1) AP9901637A0 (en)
AR (1) AR011178A1 (en)
AU (1) AU6825198A (en)
BG (1) BG103779A (en)
BR (1) BR9808305A (en)
CA (1) CA2282851A1 (en)
CO (1) CO4940415A1 (en)
EA (1) EA199900710A1 (en)
EE (1) EE9900387A (en)
GB (1) GB9704498D0 (en)
HR (1) HRP980114A2 (en)
HU (1) HUP0002109A2 (en)
ID (1) ID24207A (en)
IL (1) IL131489A0 (en)
IS (1) IS5166A (en)
NO (1) NO994303L (en)
NZ (1) NZ337315A (en)
OA (1) OA11154A (en)
PE (1) PE51399A1 (en)
PL (1) PL335652A1 (en)
SK (1) SK119699A3 (en)
TR (1) TR199902117T2 (en)
WO (1) WO1998039327A1 (en)
YU (1) YU43499A (en)
ZA (1) ZA981791B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
ID24207A (en) 2000-07-13
PL335652A1 (en) 2000-05-08
AU6825198A (en) 1998-09-22
HUP0002109A2 (en) 2001-04-28
BG103779A (en) 2000-06-30
YU43499A (en) 2000-12-28
BR9808305A (en) 2000-05-16
HRP980114A2 (en) 1998-12-31
TR199902117T2 (en) 2000-03-21
JP2001513796A (en) 2001-09-04
AP9901637A0 (en) 1999-09-30
PE51399A1 (en) 1999-06-07
OA11154A (en) 2003-04-16
CN1249750A (en) 2000-04-05
KR20000075907A (en) 2000-12-26
CA2282851A1 (en) 1998-09-11
CO4940415A1 (en) 2000-07-24
NZ337315A (en) 2001-02-23
WO1998039327A1 (en) 1998-09-11
SK119699A3 (en) 2000-05-16
AR011178A1 (en) 2000-08-02
NO994303D0 (en) 1999-09-03
EA199900710A1 (en) 2000-04-24
ZA981791B (en) 1999-09-03
IS5166A (en) 1999-08-27
IL131489A0 (en) 2001-01-28
EE9900387A (en) 2000-04-17
NO994303L (en) 1999-11-03
EP0966463A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
GB9705361D0 (en) Chemical compounds
GB9704208D0 (en) Chemical compounds
GB9708530D0 (en) Chemical compounds
GB9703201D0 (en) Chemical compounds
GB9708119D0 (en) Chemical compounds
GB9704498D0 (en) Chemical compound
GB9705212D0 (en) Chemical compounds
GB9706707D0 (en) Chemical compounds
GB9711994D0 (en) Chemical compounds
GB9715768D0 (en) Chemical compounds
GB9719002D0 (en) Chemical compound
GB9703350D0 (en) Chemical compound
GB9725602D0 (en) Chemical compound
GB9705796D0 (en) Chemical compound
GB9707452D0 (en) Chemical compounds
GB9711708D0 (en) Chemical compounds
GB9704223D0 (en) Chemical compounds
GB9704224D0 (en) Chemical compounds
GB9704809D0 (en) Chemical compounds
GB9704151D0 (en) Chemical compounds
GB9703200D0 (en) Chemical compounds
GB9705830D0 (en) Chemical compounds
GB9706668D0 (en) Chemical compounds
GB9703136D0 (en) Chemical compounds
GB9703027D0 (en) Chemical compounds